Not Enough Cancer Drugs, Too Many Price Controls

11-11-2012 Wall Street JournalComments (0)


Almost all drug shortages have come about after their price has plummeted, and the problem is compounded by the fact that many generics have few suppliers. For example in 2010, 90% of all generic injectable oncology drugs were produced by three or ...

Read more on Wall Street Journal

Your Comments

Login to add a comment

There are no comments yet. Be the first and leave a response!

Back to top